Pyruvate is a prospective alkalizer to correct hypoxic lactic acidosis

Type A lactic acidosis resulted from hypoxic mitochondrial dysfunction is an independent predictor of mortality for critically ill patients. However, current therapeutic agents are still in shortage and can even be harmful. This paper reviewed data regarding lactic acidosis treatment and recommended...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ying, Huang, Ya, Yang, Jing, Zhou, Fang-Qiang, Zhao, Lian, Zhou, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918562/
https://www.ncbi.nlm.nih.gov/pubmed/29695298
http://dx.doi.org/10.1186/s40779-018-0160-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918562/
https://www.ncbi.nlm.nih.gov/pubmed/29695298
http://dx.doi.org/10.1186/s40779-018-0160-y

Ejemplares similares